Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 95%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,694
Total Claims
$1.3M
Drug Cost
704
Beneficiaries
$1,860
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+195%
Opioid rate vs peers
7.6% vs 2.6% avg
+74%
Cost per patient vs peers
$1,860 vs $1,068 avg
+30%
Brand preference vs peers
11.7% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.6%
Opioid Rate
1,042
Opioid Claims
$46K
Opioid Cost
14.8%
Long-Acting Rate
Brand vs Generic
Brand: 1,583 claims · $1.0M
Generic: 11,982 claims · $253K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 156 | $137K |
| Dulaglutide | 49 | $59K |
| Rivaroxaban | 71 | $55K |
| Fluticasone/Umeclidin/Vilanter | 48 | $51K |
| Dapagliflozin Propanediol | 51 | $49K |
| Semaglutide | 48 | $49K |
| Sacubitril/Valsartan | 48 | $48K |
| Dapaglifloz Propaned/Metformin | 44 | $38K |
| Insulin Glargine,hum.Rec.Anlog | 43 | $38K |
| Empagliflozin | 30 | $37K |
| Insulin Detemir | 22 | $34K |
| Evolocumab | 46 | $33K |
| Insulin Aspart | 17 | $22K |
| Insulin Degludec | 31 | $20K |
| Insulin Lispro | 17 | $19K |
Prescribing Profile
Patient Profile
73
Avg Age
46%
Female
0.99
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About